Liberty Health Sciences Signs Exclusive Agreement to Bring Award-Winning Mary's Medicinals Cannabis Products into Massachusetts

Liberty Health Sciences Signs Exclusive Agreement to Bring Award-Winning Mary's Medicinals Cannabis Products into Massachusetts

Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) today announced the expansion of the Company’s partnership with Colorado-based MM Technology Holdings, LLC to be the exclusive provider of the award-winning lineup of Mary’s Medicinals® cannabis products in Massachusetts.

Under the agreement, Liberty will produce and distribute Mary’s suite of innovative cannabis products, with many different novel delivery methods, under permit in Massachusetts for both medical and recreational users, when permitted.

“We’re very excited to extend our partnership with Mary’s into Massachusetts, providing consumers with access to award-winning cannabis products featuring safe and effective alternative delivery methods,” said George Scorsis, Director and CEO of Liberty. “Liberty has always focused on providing high-quality, clean and safe pharmaceutical grade cannabis, and partnerships with innovative brands such as Mary’s ensures we’re also providing consumers with exceptional selection and choices in the best across the industry.

Best known as the developer and exclusive distributor of this award-winning Transdermal Cannabis Patch, Mary’s innovative products are forged at the intersection of technology and horticulture and are changing how people view and utilize cannabis. Mary’s develops products and delivery methods that maximize the benefits of cannabinoids, terpenes and other plant nutrients. The arrangement gives Liberty exclusive rights to produce and market the following products in Massachusetts:
Most importantly, the company is dedicated to developing proven innovative products that have garnered numerous accolades such as the 2014 Invention of the Year in the Cannabis Business Awards, Most Innovative Product at the CannAwards and Best New Product at the High Times Cannabis Cup.

“We are pleased to offer our unique and creative products in the Bay State,” said Lynn Honderd, CEO of Mary’s. “We look forward to providing an entirely new menu of choices for health and recreational users that are clean, safe, and thoroughly curated.”

In October 2017, Liberty and Mary’s announced an exclusive licensing and raw materials arrangement to bring Mary’s Medicinals® cannabis products to Florida.

For more information on Liberty, please visit www.libertyhealthsciences.com

Liberty’s strict investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities.   Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost manufacturer.   Liberty leverages commercial greenhouse knowledge to supply high-quality, clean and safe pharmaceutical grade cannabis to patients.

For more information, please visit libertyhealthsciences.com

Read original release

Published at Fri, 25 May 2018 14:55:01 +0000

Posted in: News

Comments are closed.